VR During Chest Tube Removal After CABG
VR-CABG
Effects of Virtual Reality During Chest Tube Removal in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
2 other identifiers
interventional
82
1 country
1
Brief Summary
he purpose of this clinical trial is to evaluate whether virtual reality can reduce pain, anxiety, and physiological stress during chest tube removal in adult patients undergoing coronary artery bypass graft (CABG) surgery. The main questions it aims to answer are:
- Does virtual reality reduce pain intensity during chest tube removal?
- Does virtual reality reduce anxiety levels and stabilize vital signs? Researchers will compare patients receiving virtual reality with patients receiving routine care to determine whether virtual reality improves patient comfort during the procedure. Participants will:
- Be randomly assigned to a virtual reality group or a control group
- Have their pain, anxiety, and vital signs measured before the procedure
- Undergo chest tube removal with or without virtual reality
- Have their pain, anxiety, and vital signs measured again after the procedure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2026
CompletedFirst Submitted
Initial submission to the registry
October 15, 2026
CompletedFirst Posted
Study publicly available on registry
October 23, 2026
CompletedOctober 23, 2026
October 1, 2026
1.1 years
October 15, 2026
October 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity (VAS)
Pain intensity is assessed using the Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, while a score of 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Immediately before and immediately after chest tube removal
Secondary Outcomes (1)
Anksiyete - State-Trait Anxiety Inventory (STAI-State)
Before chest tube removal (baseline) and immediately after completion of chest tube removal (post-intervention).
Study Arms (2)
Virtual Reality Group
EXPERIMENTALPatients in the experimental group received a virtual reality intervention using a virtual reality headset during chest tube removal following coronary artery bypass graft surgery, in addition to standard care. The intervention was designed to reduce pain and anxiety associated with chest tube removal.
Control Group
NO INTERVENTIONControl
Interventions
Participants in the experimental group receive a virtual reality intervention using the VR Shinecon G04EA virtual reality headset, which displays immersive nature videos accompanied by audio. The intervention begins 5 minutes before chest tube removal and continues throughout the procedure. The virtual reality headset is used as a non-pharmacological distraction method to reduce pain and anxiety associated with chest tube removal. The intervention is administered in addition to routine postoperative care in the cardiovascular intensive care unit following coronary artery bypass graft surgery.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- Undergoing coronary artery bypass graft surgery
- Presence of chest tube
- Conscious and oriented
- Able to communicate in Turkish
- Voluntarily agrees to participate
You may not qualify if:
- Chronic pain condition requiring regular analgesic use
- Migraine, vertigo, or history of dizziness
- Visual impairment preventing VR use
- Psychiatric disorders
- Undergoing different cardiac surgical procedures
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maltepe University
Istanbul, 0000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist Prof.
Study Record Dates
First Submitted
October 15, 2026
First Posted
October 23, 2026
Study Start
December 5, 2024
Primary Completion
January 5, 2026
Study Completion
March 2, 2026
Last Updated
October 23, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share